inqovi
(CEDAZURIDINE and DECITABINE)Taiho Pharmaceutical Co., Ltd.
Usage: INQOVI is indicated for the treatment of adult patients with myelodysplastic syndromes (MDS), including various subtypes and risk groups as per the International Prognostic Scoring System, applicable to both previously treated and untreated cases.